Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
SNGX Stock Summary
Top 10 Correlated ETFs
SNGX
In the News
SNGX Financial details
Company Rating
Neutral
Market Cap
4.06M
Income
-6.14M
Revenue
839.36K
Book val./share
0.24
Cash/share
0.81
Dividend
-
Dividend %
-
Employees
13
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-0.98
Forward P/E
-
PEG
0.12
P/S
9.4
P/B
2.14
P/C
0.62
P/FCF
-0.87
Quick Ratio
1.88
Current Ratio
1.99
Debt / Equity
1.34
LT Debt / Equity
0.4
-
-
EPS (TTM)
-0.92
EPS next Y
-
EPS next Q
-
EPS this Y
-83.58%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-35.79%
Revenue last 5Y
-28.93%
Revenue Q/Q
87.68%
EPS Q/Q
12.5%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0%
Inst Trans
0%
ROA
-82%
ROE
-887%
ROC
-1.58%
Gross Margin
32%
Oper. Margin
-950%
Profit Margin
-961%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.3705-4.2
52W High
-
52W Low
-
RSI
40
Rel Volume
23.43
Avg Volume
164.08K
Volume
3.84M
Perf Week
7.48%
Perf Month
-36.25%
Perf Quarter
-1.98%
Perf Half Y
-4.8%
-
-
-
-
Beta
1.851
-
-
Volatility
0.04%, 0.11%
Prev Close
5.91%
Price
0.4999
Change
-8.44%
SNGX Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 3.58 | 1.29 | 0.31 | 0.33 | 0.11 | |
Net income per share | -7.24 | -9.65 | -4.69 | -4.81 | -0.79 | |
Operating cash flow per share | -5.81 | -6.25 | -4.39 | -4.41 | -1.11 | |
Free cash flow per share | -5.84 | -6.25 | -4.39 | -4.41 | -1.11 | |
Cash per share | 4.2 | 10.19 | 9.73 | 4.65 | 1.09 | |
Book value per share | 1.13 | 2.04 | 4.01 | -0.86 | 0.33 | |
Tangible book value per share | 1.11 | 2.03 | 4 | -0.86 | 0.33 | |
Share holders equity per share | 1.13 | 2.04 | 4.01 | -0.86 | 0.33 | |
Interest debt per share | 0.1 | 5.74 | 4.05 | 3.85 | 0.44 | |
Market cap | 28.1M | 35.18M | 26.49M | 19.38M | 5.87M | |
Enterprise value | 22.8M | 27.01M | 10.41M | 16.26M | 922.79K | |
P/E ratio | -3 | -1.99 | -2.11 | -1.4 | -0.96 | |
Price to sales ratio | 6.07 | 14.91 | 32.13 | 20.42 | 7 | |
POCF ratio | -3.74 | -3.07 | -2.26 | -1.53 | -0.68 | |
PFCF ratio | -3.73 | -3.07 | -2.25 | -1.53 | -0.68 | |
P/B Ratio | 19.28 | 9.4 | 2.47 | -7.84 | 2.33 | |
PTB ratio | 19.28 | 9.4 | 2.47 | -7.84 | 2.33 | |
EV to sales | 4.93 | 11.45 | 12.62 | 17.14 | 1.1 | |
Enterprise value over EBITDA | -2.27 | -1.47 | -0.81 | -1.16 | -0.11 | |
EV to operating cash flow | -3.04 | -2.36 | -0.89 | -1.29 | -0.11 | |
EV to free cash flow | -3.02 | -2.36 | -0.89 | -1.28 | -0.11 | |
Earnings yield | -0.33 | -0.5 | -0.47 | -0.71 | -1.05 | |
Free cash flow yield | -0.27 | -0.33 | -0.44 | -0.65 | -1.46 | |
Debt to equity | 0.09 | 2.81 | 0.93 | -4.14 | 1.34 | |
Debt to assets | 0.02 | 0.53 | 0.37 | 0.72 | 0.35 | |
Net debt to EBITDA | 0.53 | 0.44 | 1.25 | 0.22 | 0.59 | |
Current ratio | 1.19 | 3.2 | 4.22 | 0.84 | 1.55 | |
Interest coverage | 0 | -1.7K | -15.03 | -17.15 | -173.77 | |
Income quality | 0.8 | 0.65 | 0.94 | 0.92 | 1.4 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.75 | 1.69 | 5.88 | 7.05 | 5.34 | |
Research and developement to revenue | 1.75 | 6.42 | 10.18 | 8.37 | 3.94 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | -0.01 | 0 | -0.01 | -0.01 | 0 | |
Capex to depreciation | -0.55 | -0.11 | -0.35 | -0.53 | 0 | |
Stock based compensation to revenue | 0.08 | 0.17 | 0.44 | 0.35 | 0.44 | |
Graham number | 13.56 | 21.06 | 20.57 | 9.65 | 2.41 | |
ROIC | -5.54 | -1.22 | -0.58 | -1.6 | -1.1 | |
Return on tangible assets | -1.21 | -0.89 | -0.47 | -0.97 | -0.63 | |
Graham Net | 0.15 | 1.61 | 3.77 | -1.12 | 0.17 | |
Working capital | 1.18M | 13.39M | 20.28M | -2.66M | 3.36M | |
Tangible asset value | 1.44M | 3.72M | 10.71M | -2.47M | 2.52M | |
Net current asset value | 1.18M | 3.32M | 10.42M | -2.9M | 2.23M | |
Invested capital | 0.09 | 2.81 | 0.93 | -4.14 | 1.34 | |
Average receivables | 1.33M | 1.01M | 403.8K | 231.02K | 207.24K | |
Average payables | 2.43M | 2.43M | 2.53M | 3.4M | 2.49M | |
Average inventory | 1 | 1 | 0 | 0.5 | 0.5 | |
Days sales outstanding | 115.33 | 87.38 | 107.48 | 84.36 | 84.86 | |
Days payables outstanding | 279.88 | 426.92 | 1.47K | 2.56K | 541.81 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 3.16 | 4.18 | 3.4 | 4.33 | 4.3 | |
Payables turnover | 1.3 | 0.85 | 0.25 | 0.14 | 0.67 | |
Inventory turnover | 1.78M | 0 | 0 | 550.82K | 0 | |
ROE | -6.42 | -4.73 | -1.17 | 5.58 | -2.43 | |
Capex per share | -0.02 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.13 | 0.09 | 0.03 | 0.01 | 0.02 | |
Net income per share | -1.7 | -0.36 | -0.22 | -0.16 | -0.18 | |
Operating cash flow per share | -1.26 | -0.74 | -0.27 | -0.26 | -0.18 | |
Free cash flow per share | -1.25 | -0.74 | -0.27 | -0.26 | -0.18 | |
Cash per share | 4.63 | 3.52 | 1.82 | 0.99 | 0.81 | |
Book value per share | -0.86 | -1.16 | 0.8 | 0.41 | 0.24 | |
Tangible book value per share | -0.86 | -1.16 | 0.8 | 0.41 | 0.24 | |
Share holders equity per share | -0.86 | -1.16 | 0.8 | 0.41 | 0.24 | |
Interest debt per share | 3.61 | 3.13 | 0.44 | 0.31 | 0.33 | |
Market cap | 19.46M | 5.74M | 5.07M | 5.79M | 7.86M | |
Enterprise value | 16.34M | 4.7M | -4.95M | -1.33M | 2.91M | |
P/E ratio | -0.99 | -1.37 | -0.79 | -0.87 | -1.08 | |
Price to sales ratio | 53.16 | 22.33 | 24.51 | 44.36 | 32.1 | |
POCF ratio | -5.36 | -2.65 | -2.64 | -2.15 | -4.3 | |
PFCF ratio | -5.38 | -2.65 | -2.64 | -2.15 | -4.3 | |
P/B Ratio | -7.88 | -1.7 | 0.87 | 1.37 | 3.12 | |
PTB ratio | -7.88 | -1.7 | 0.87 | 1.37 | 3.12 | |
EV to sales | 44.64 | 18.28 | -23.94 | -10.22 | 11.87 | |
Enterprise value over EBITDA | -4.58 | -2.19 | 3.06 | 0.73 | -1.24 | |
EV to operating cash flow | -4.5 | -2.17 | 2.58 | 0.5 | -1.59 | |
EV to free cash flow | -4.52 | -2.17 | 2.58 | 0.5 | -1.59 | |
Earnings yield | -0.25 | -0.18 | -0.32 | -0.29 | -0.23 | |
Free cash flow yield | -0.19 | -0.38 | -0.38 | -0.46 | -0.23 | |
Debt to equity | -4.14 | -2.72 | 0.54 | 0.75 | 1.34 | |
Debt to assets | 0.72 | 0.83 | 0.23 | 0.28 | 0.35 | |
Net debt to EBITDA | 0.87 | 0.49 | 6.19 | 3.92 | 2.1 | |
Current ratio | 0.84 | 0.94 | 2.34 | 1.99 | 1.55 | |
Interest coverage | -19.76 | 20.7 | -27.08 | -26.81 | 0 | |
Income quality | 0.97 | 2.07 | 1.19 | 1.62 | 1 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 3.94 | 4.8 | 4.3 | 7.46 | 5.65 | |
Research and developement to revenue | 6.44 | 3.68 | 3.69 | 6.33 | 3.17 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0.04 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 4.32 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0.31 | 0.29 | 0.44 | 0.5 | 0.58 | |
Graham number | 5.73 | 3.06 | 2 | 1.21 | 0.98 | |
ROIC | -0.58 | -0.17 | -0.18 | -0.22 | -0.3 | |
Return on tangible assets | -0.34 | -0.09 | -0.12 | -0.15 | -0.19 | |
Graham Net | -1.12 | -1.39 | 0.72 | 0.32 | 0.13 | |
Working capital | -2.66M | -654.73K | 7.71M | 5.45M | 3.36M | |
Tangible asset value | -2.47M | -3.39M | 5.8M | 4.22M | 2.52M | |
Net current asset value | -2.9M | -3.77M | 5.45M | 3.89M | 2.23M | |
Invested capital | -4.14 | -2.72 | 0.54 | 0.75 | 1.34 | |
Average receivables | 225.22K | 231.06K | 190.91K | 113.97K | 142.03K | |
Average payables | 4.02M | 3.32M | 2.62M | 1.97M | 1.29M | |
Average inventory | 1 | 1 | 1 | 0.5 | 0 | |
Days sales outstanding | 53.92 | 84.96 | 60.47 | 61.34 | 71.74 | |
Days payables outstanding | 2.56K | 1.1K | 1.21K | 1.19K | 448.2 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 1.67 | 1.06 | 1.49 | 1.47 | 1.25 | |
Payables turnover | 0.04 | 0.08 | 0.07 | 0.08 | 0.2 | |
Inventory turnover | 135.87K | 226.04K | 184.02K | 0 | 0 | |
ROE | 1.99 | 0.31 | -0.28 | -0.39 | -0.72 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
SNGX Frequently Asked Questions
What is Soligenix, Inc. stock symbol ?
Soligenix, Inc. is a US stock , located in Princeton of Nj and trading under the symbol SNGX
What is Soligenix, Inc. stock quote today ?
Soligenix, Inc. stock price is $0.4999 today.
Is Soligenix, Inc. stock public?
Yes, Soligenix, Inc. is a publicly traded company.